Hospital Universitari de Tarragona Joan XXIII

Tarragona, Catalonia 43007

0 studies enrolling now · 3 studies all time

What they study most

Cardiovascular Disease, Severe Sepsis

Studies at this site

• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis — Paused